Contract Pharmaceutical Manufacturing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4096215
- 110 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Contract Pharmaceutical Manufacturing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Contract Pharmaceutical Manufacturing market segmented into
Big Pharma
Finished Dosage Formulations
Based on the end-use, the global Contract Pharmaceutical Manufacturing market classified into
Big Pharma
Specialty/Midsize
Generics
Others
Based on geography, the global Contract Pharmaceutical Manufacturing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY
2.1 Summary about Contract Pharmaceutical Manufacturing Industry
2.2 Contract Pharmaceutical Manufacturing Market Trends
2.2.1 Contract Pharmaceutical Manufacturing Production & Consumption Trends
2.2.2 Contract Pharmaceutical Manufacturing Demand Structure Trends
2.3 Contract Pharmaceutical Manufacturing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Active Pharmaceutical Ingredients
4.2.2 Finished Dosage Formulations
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Big Pharma
4.3.2 Specialty/Midsize
4.3.3 Generics
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Active Pharmaceutical Ingredients
5.2.2 Finished Dosage Formulations
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Big Pharma
5.3.2 Specialty/Midsize
5.3.3 Generics
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Active Pharmaceutical Ingredients
6.2.2 Finished Dosage Formulations
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Big Pharma
6.3.2 Specialty/Midsize
6.3.3 Generics
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Active Pharmaceutical Ingredients
7.2.2 Finished Dosage Formulations
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Big Pharma
7.3.2 Specialty/Midsize
7.3.3 Generics
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Active Pharmaceutical Ingredients
8.2.2 Finished Dosage Formulations
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Big Pharma
8.3.2 Specialty/Midsize
8.3.3 Generics
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Active Pharmaceutical Ingredients
9.2.2 Finished Dosage Formulations
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Big Pharma
9.3.2 Specialty/Midsize
9.3.3 Generics
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Catalent
10.1.2 DPx
10.1.3 Lonza
10.1.4 Piramal Healthcare
10.1.5 Aenova
10.1.6 Jubilant
10.1.7 Famar
10.1.8 Boehringer Ingelheim
10.1.9 Fareva Holding
10.1.10 AbbVie
10.1.11 Nipro Corp
10.1.12 Vetter
10.1.13 Sopharma
10.1.14 DPT Laboratories
10.1.15 Recipharm
10.1.16 NextPharma
10.1.17 Dishman
10.1.18 Aesica
10.2 Contract Pharmaceutical Manufacturing Sales Date of Major Players (2017-2020e)
10.2.1 Catalent
10.2.2 DPx
10.2.3 Lonza
10.2.4 Piramal Healthcare
10.2.5 Aenova
10.2.6 Jubilant
10.2.7 Famar
10.2.8 Boehringer Ingelheim
10.2.9 Fareva Holding
10.2.10 AbbVie
10.2.11 Nipro Corp
10.2.12 Vetter
10.2.13 Sopharma
10.2.14 DPT Laboratories
10.2.15 Recipharm
10.2.16 NextPharma
10.2.17 Dishman
10.2.18 Aesica
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Contract Pharmaceutical Manufacturing Product Type Overview
2.Table Contract Pharmaceutical Manufacturing Product Type Market Share List
3.Table Contract Pharmaceutical Manufacturing Product Type of Major Players
4.Table Brief Introduction of Catalent
5.Table Brief Introduction of DPx
6.Table Brief Introduction of Lonza
7.Table Brief Introduction of Piramal Healthcare
8.Table Brief Introduction of Aenova
9.Table Brief Introduction of Jubilant
10.Table Brief Introduction of Famar
11.Table Brief Introduction of Boehringer Ingelheim
12.Table Brief Introduction of Fareva Holding
13.Table Brief Introduction of AbbVie
14.Table Brief Introduction of Nipro Corp
15.Table Brief Introduction of Vetter
16.Table Brief Introduction of Sopharma
17.Table Brief Introduction of DPT Laboratories
18.Table Brief Introduction of Recipharm
19.Table Brief Introduction of NextPharma
20.Table Brief Introduction of Dishman
21.Table Brief Introduction of Aesica
22.Table Products & Services of Catalent
23.Table Products & Services of DPx
24.Table Products & Services of Lonza
25.Table Products & Services of Piramal Healthcare
26.Table Products & Services of Aenova
27.Table Products & Services of Jubilant
28.Table Products & Services of Famar
29.Table Products & Services of Boehringer Ingelheim
30.Table Products & Services of Fareva Holding
31.Table Products & Services of AbbVie
32.Table Products & Services of Nipro Corp
33.Table Products & Services of Vetter
34.Table Products & Services of Sopharma
35.Table Products & Services of DPT Laboratories
36.Table Products & Services of Recipharm
37.Table Products & Services of NextPharma
38.Table Products & Services of Dishman
39.Table Products & Services of Aesica
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
